Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;14(4):372–377. doi: 10.1111/j.1750-3639.2004.tb00080.x

Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas

Masahiro Mizoguchi 1, Catherine L Nutt 1, Gayatry Mohapatra 1, David N Louis 1,✉
PMCID: PMC8095817  PMID: 15605984

Abstract

Genetic alterations of PI3K (phosphoinositide 3‐kinase) subunits have been documented in a number of tumor types, with increased PI3K activity linked to gene amplification and mutation of catalytic subunits, as well as mutations of regulatory subunits. Among high grade gliomas, activation of the PI3K‐AKT signaling pathway through loss of PTEN function is common. We therefore investigated whether genetic alteration of class IA PI3Ks might provide a mechanism for deregulation of this pathway in glioblastomas. We studied a series of glioblastomas with FISH to assess copy number of catalytic subunits (PIK3CA and PIK3CD) and with PCR‐SSCP to screen for somatic mutations of conserved regions of both catalytic and regulatory subunits. FISH revealed frequent balanced copy number increases of both PIK3CA and PIK3CD, and one case showed an extra copy limited to PIK3CA. One glioblastoma exhibited a 9‐bp deletion that encompassed the exon‐intron junction of exon 12 of PIK3R1, documenting for the first time a mutation within a PI3K regulatory subunit in human glioblastoma. This deletion would be predicted to yield a truncated protein that lacks the inhibitory domain, resulting in increased PI3K activity. Furthermore, the case with selected PIK3CA copy number gain and the case with a truncating PIK3R1 mutation both featured AKT activation without PTEN mutation. These results suggest that genetic alterations of class IA PI3K subunit genes can occasionally play a role in human glioblastoma by activating the PI3K‐AKT signaling pathway independently of PTEN mutation.

Full Text

The Full Text of this article is available as a PDF (197.8 KB).

REFERENCES

  • 1. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000. [PubMed] [Google Scholar]
  • 2. Cantley LC (2002) The phosphoinositide 3‐ki‐nase pathway. Science 296:1655–1657. [DOI] [PubMed] [Google Scholar]
  • 3. Chan TO, Rodeck U, Chan AM, Kimmelman AC, Rittenhouse SE, Panayotou G, Tsichlis PN (2002) Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3‐ki‐nase regulatory subunit. Cancer Cell 1:181–191. [DOI] [PubMed] [Google Scholar]
  • 4. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS (2003) Analysis of the phosphatidylinositol 3′‐kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63:2742–2746. [PubMed] [Google Scholar]
  • 5. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer‐Puttlitz B, Louis DN, Schramm J, Wiestler O D, Parsons R, Eng C, von Deimling A (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264. [DOI] [PubMed] [Google Scholar]
  • 6. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genetics 25:55–57. [DOI] [PubMed] [Google Scholar]
  • 7. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array‐based comparative genomic hybridization. Lab Invest 81:717–723. [DOI] [PubMed] [Google Scholar]
  • 8. Jimenez C, Jones DR, Rodriguez‐Viciana P, Gonzalez‐Garcia A, Leonardo E, Wennstrom S, von Kobbe C, Toran JL, Borlado LR, Calvo V, Copin SG, Albar JP, Gaspar ML, Diez E, Marcos MA, Downward J, Martinez AC, Merida I, Carrera AC (1998) Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3‐kinase. EMBO J 17:743–753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Jucker M, Sudel K, Horn S, Sickel M, Wegner W, Fiedler W, Feldman RA (2002) Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3‐kinase in a Hodgkin's lymphoma‐derived cell line (CO). Leukemia 16:894–901. [DOI] [PubMed] [Google Scholar]
  • 10. Knobbe CB, Reifenberger G (2003) Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl‐Inositol‐3′‐Kinase/Protein Kinase B (Akt) Signal transduction Pathway in Glioblastomas. Brain Pathol 13:507–508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947. [DOI] [PubMed] [Google Scholar]
  • 12. Louis DN, Rubio MP, Correa KM, Gusella JF, von Deimling A (1993) Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 52:507–515. [DOI] [PubMed] [Google Scholar]
  • 13. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang‐Peng J, Liu JM, Yang DM, Yang WK, Shen CY (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19:2739–2744. [DOI] [PubMed] [Google Scholar]
  • 14. Moscatello DK, Holgado‐Madruga M, Emlet DR, Montgomery RB, Wong AJ (1998) Constitutive activation of phosphatidylinositol 3‐kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem 273:200–206. [DOI] [PubMed] [Google Scholar]
  • 15. Neubauer A, Neubauer B, He M, Effert P, Iglehart D, Frye RA, Liu E (1992) Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 7:1019–1025. [PubMed] [Google Scholar]
  • 16. Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL, Louis DN (2003) Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 63:413–416. [PubMed] [Google Scholar]
  • 17. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ, Phillips WA (2001) The phosphatidylinositol 3′‐kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61:7426–7429. [PubMed] [Google Scholar]
  • 18. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH (1997) PTEN gene mutations are seen in high‐grade but not in low‐grade gliomas. Cancer Res 57:4187–4190. [PubMed] [Google Scholar]
  • 19. Sasaki H, Betensky RA, Cairncross JG, Louis DN (2002) DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Cancer Res 62:1790–1796. [PubMed] [Google Scholar]
  • 20. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554. [DOI] [PubMed] [Google Scholar]
  • 21. Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN (2001) PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159:359–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Schmidt EE, Ichimura K, Goike HM, Moshref A, Liu L, Collins VP (1999) Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. J Neuropathol Exp Neurol 58:1170–1183. [DOI] [PubMed] [Google Scholar]
  • 23. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genetics 21:99–102. [DOI] [PubMed] [Google Scholar]
  • 24. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61:6674–6678. [PubMed] [Google Scholar]
  • 25. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3‐Kinase AKT pathway in human cancer. Nat Rev Cancer 2:489–501. [DOI] [PubMed] [Google Scholar]
  • 26. Woenckhaus J, Steger K, Werner E, Fenic I, Gamerdinger U, Dreyer T, Stahl U (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198:335–342. [DOI] [PubMed] [Google Scholar]
  • 27. Zhu Y, Parada LF (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2:616–626. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES